Eric Sagerman
Salk Institute for Biological Studies listed Eric Sagerman as TRUSTEE on its 2024 Form 990.
Reported compensation by filing year
Each entry comes from one tax return.
Tax year
Reported total$0
- From filing organization
- $0
- From related organizations
- $0
- Other compensation
- $0
Tax year
Reported total$0
- From filing organization
- $0
- From related organizations
- $0
- Other compensation
- $0
Tax year
Reported total$0
- From filing organization
- $0
- From related organizations
- $0
- Other compensation
- $0
Tax year
Reported total$0
- From filing organization
- $0
- From related organizations
- $0
- Other compensation
- $0
Tax year
Reported total$0
- From filing organization
- $0
- From related organizations
- $0
- Other compensation
- $0
Tax year
Reported total$0
- From filing organization
- $0
- From related organizations
- $0
- Other compensation
- $0
Tax year
Reported total$0
- From filing organization
- $0
- From related organizations
- $0
- Other compensation
- $0
Tax year
Reported total$0
- From filing organization
- $0
- From related organizations
- $0
- Other compensation
- $0
Tax year
Reported total$0
- From filing organization
- $0
- From related organizations
- $0
- Other compensation
- $0
Official bio
Eric Sagerman has served on Salk’s Board of Trustees since 2016. He is currently co-chair of the Investment Committee. Previously, he served as managing director and head of strategy at Allianz Global Investors, following his role as managing director at Nicholas Applegate Capital Management.